Invention Grant
US08729109B2 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1phosphate receptors modulators
有权
3-（4-（5-苯基-1,2,4-恶二唑-3-基）苯氧基）丙-2-醇衍生物作为鞘氨醇1-磷酸受体调节剂
- Patent Title: 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1phosphate receptors modulators
- Patent Title (中): 3-（4-（5-苯基-1,2,4-恶二唑-3-基）苯氧基）丙-2-醇衍生物作为鞘氨醇1-磷酸受体调节剂
-
Application No.: US13604152Application Date: 2012-09-05
-
Publication No.: US08729109B2Publication Date: 2014-05-20
- Inventor: Janet A. Takeuchi , Ling Li , Ken Chow
- Applicant: Janet A. Takeuchi , Ling Li , Ken Chow
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D271/06
Abstract:
The present invention relates to novel oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
Information query
